OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions... Show more
a manufacturer of oral fluid specimen collection devices
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, OSUR has been loosely correlated with IQV. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OSUR jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To OSUR | 1D Price Change % | ||
|---|---|---|---|---|
| OSUR | 100% | +0.12% | ||
| IQV - OSUR | 43% Loosely correlated | -0.14% | ||
| MTD - OSUR | 42% Loosely correlated | +0.26% | ||
| RVTY - OSUR | 41% Loosely correlated | -1.05% | ||
| IART - OSUR | 41% Loosely correlated | -1.12% | ||
| INGN - OSUR | 38% Loosely correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To OSUR | 1D Price Change % |
|---|---|---|
| OSUR | 100% | +0.12% |
| Pharmaceuticals: Other industry (54 stocks) | 31% Poorly correlated | -0.45% |
| Pharmaceuticals industry (160 stocks) | 20% Poorly correlated | -0.79% |
On July 13, 2026, the Stochastic Oscillator for OSUR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OSUR advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 138 cases where OSUR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for OSUR moved out of overbought territory on June 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on July 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OSUR as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for OSUR turned negative on June 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSUR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
OSUR broke above its upper Bollinger Band on June 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OSUR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.945) is normal, around the industry mean (4.675). P/E Ratio (26.667) is within average values for comparable stocks, (193.447). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.510). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (2.746) is also within normal values, averaging (83.877).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OSUR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.